These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6602847)

  • 1. A rapid, large scale purification procedure for gibbon interleukin 2.
    Henderson LE; Hewetson JF; Hopkins RF; Sowder RC; Neubauer RH; Rabin H
    J Immunol; 1983 Aug; 131(2):810-5. PubMed ID: 6602847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification of murine B cell stimulatory factor (BSF)-1.
    Ohara J; Lahet S; Inman J; Paul WE
    J Immunol; 1985 Oct; 135(4):2518-23. PubMed ID: 3875657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the molecular nature of human interleukin 1.
    Auron PE; Warner SJ; Webb AC; Cannon JG; Bernheim HA; McAdam KJ; Rosenwasser LJ; LoPreste G; Mucci SF; Dinarello CA
    J Immunol; 1987 Mar; 138(5):1447-56. PubMed ID: 3492551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
    Frank MB; Watson J; Mochizuki D; Gillis S
    J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of avian T cell growth factor and immune interferon using gel filtration high resolution chromatography.
    Fredericksen TL; Sharma JM
    Prog Clin Biol Res; 1987; 238():145-56. PubMed ID: 3110790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and initial characterization of the lymphokine soluble immune response suppressor.
    Aune TM; Webb DR; Pierce CW
    J Immunol; 1983 Dec; 131(6):2848-52. PubMed ID: 6417233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and partial sequence analysis of murine B cell growth factor II (interleukin 5).
    McKenzie DT; Filutowicz HI; Swain SL; Dutton RW
    J Immunol; 1987 Oct; 139(8):2661-8. PubMed ID: 3498767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of human interleukin 1.
    Lachman LB; Page SO; Metzgar RS
    J Supramol Struct; 1980; 13(4):457-66. PubMed ID: 6785531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedures for the purification of interleukin 3 to homogeneity.
    Ihle JN; Keller J; Henderson L; Klein F; Palaszynski E
    J Immunol; 1982 Dec; 129(6):2431-6. PubMed ID: 6815268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.
    Rabin H; Hopkins RF; Ruscetti FW; Neubauer RH; Brown RL; Kawakami TG
    J Immunol; 1981 Nov; 127(5):1852-6. PubMed ID: 6975300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of human B cell growth factor.
    Mehta SR; Conrad D; Sandler R; Morgan J; Montagna R; Maizel AL
    J Immunol; 1985 Nov; 135(5):3298-302. PubMed ID: 3876383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells from lymphoepithelial thymoma produce a biochemical variant of IL-2.
    Cornaglia-Ferraris P; Ponzoni M
    Lymphokine Res; 1985; 4(3):251-63. PubMed ID: 3875768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression and characterization of recombinant human fusion protein IL-6/IL-2 (CH925).
    Zhao C; Tang P; Wang J; Mao N; Jiang F; Li X; Liu X; Zhang M; Ren Y; Du D
    Stem Cells; 1994 May; 12(3):339-47. PubMed ID: 8075595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The purification and properties of human T cell growth factor.
    Mier JW; Gallo RC
    J Immunol; 1982 Mar; 128(3):1122-7. PubMed ID: 6976987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and point-mutation analysis of human interleukin-2 (Ser-125).
    Wu G; Tu H; Shao X; Xu L; Xia Q
    Chin J Biotechnol; 1992; 8(4):219-25. PubMed ID: 1343825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression in bacteria and purification of polymorphic mouse interleukin 2 molecules.
    Matesanz F; Alcina A
    Cytokine; 1998 Apr; 10(4):249-53. PubMed ID: 9617568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.
    Welte K; Wang CY; Mertelsmann R; Venuta S; Feldman SP; Moore MA
    J Exp Med; 1982 Aug; 156(2):454-64. PubMed ID: 6980256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification to homogeneity of biologically active human interleukin 1.
    Krakauer T
    Prep Biochem; 1984-1985; 14(5):449-70. PubMed ID: 6336003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification to apparent homogeneity of murine interleukin 1.
    Mizel SB; Mizel D
    J Immunol; 1981 Mar; 126(3):834-7. PubMed ID: 6780623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies.
    Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ
    J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.